GLP‑1 Weight‑Loss Medications: Updated Pricing Guide for 2026

If you’ve been looking into weight‑loss medications like Semaglutide or Tirzepatide, you’ve probably noticed that prices can vary a lot. Some clinics offer compounded versions at lower prices, while brand‑name medications like Wegovy, Ozempic, Zepbound, and Mounjaro can cost over a thousand dollars per month. With so much conflicting information online, it’s hard to know what’s normal or affordable.

This guide gives you a clear, updated look at 2026 pricing, along with how it compares to August 2025, so you can make an informed decision.

Brand‑Name vs. Compounded GLP‑1s

Brand‑Name Medications

These include Wegovy, Ozempic, Zepbound, and Mounjaro.
They are FDA‑approved, highly effective, and widely used—but also the most expensive option, typically costing $1,000–$1,349 per month.

Compounded Medications

Compounded Semaglutide and Tirzepatide are prepared by licensed compounding pharmacies.
They are not FDA‑approved, but many patients choose them because they are significantly more affordable and easier to access through telehealth clinics.

What’s Changed in 2026?

The GLP‑1 market has shifted noticeably over the past year. Here are the biggest trends:

1. Compounded prices have increased

• Compounded Semaglutide rose from $129–$350 in 2025 to $297–$397 in 2026
  → A 40–130% increase, depending on the provider.

• Compounded Tirzepatide rose from $299–$450 in 2025 to $399–$599 in 2026
  → A 25–60% increase.

2. Brand‑name prices remain high

Wegovy and Zepbound continue to cost $1,000–$1,349 per month, with only small year‑to‑year changes.

3. Tirzepatide demand continues to grow

More patients are choosing Tirzepatide because it often produces faster weight loss.
This increased demand has pushed compounded prices upward.

2026 Pricing Snapshot

Semaglutide

• Compounded: $297–$397/month

• Brand‑name: Wegovy ~$1,349/month

Tirzepatide

• Compounded: $399–$599/month

• Brand‑name: Zepbound ~$1,023–$1,349/month

How Prices Compare to August 2025

A More Affordable Option: Our Pricing

While many clinics have raised prices significantly, our program remains one of the most cost‑effective options available because your cost depends only on:

• Your dose

• Your vial size

• Your vial concentration

This keeps pricing predictable and fair—especially compared to national averages.

Our 2026 pricing:

• Semaglutide: $21–$33 per week
  → Equivalent to $84–$132 per month, which is 60–75% lower than typical compounded pricing.

• Tirzepatide: $70–$91 per week
  → Equivalent to $280–$364 per month, which is 35–55% lower than typical compounded pricing.

For many patients, this makes treatment far more accessible than the national averages listed above.

Final Thoughts

GLP‑1 medications have transformed weight‑loss care, but pricing can be confusing. While national costs have increased since 2025—especially for compounded options—affordable pathways still exist. By structuring pricing around dose and vial size rather than flat monthly fees, our program offers a more transparent and budget‑friendly approach.

If you’re looking for a safe, supportive, and cost‑effective way to begin your GLP‑1 journey, our clinic is designed to make treatment accessible without sacrificing quality or care.